Direct-to-Consumer AI Health Services: Precision Healthcare Needs Precision Consent
Abstract
Artificial Intelligence (AI) technology has the potential to replace a visit to the doctor, with AI companies offering health services directly to the public that, until recently, could only be performed by humans. AI apps that claim to detect disease, such as skin cancer, envisage a hopeful future where everyone can access expert medical care on their phone, at a fraction of the cost of traditional healthcare. However, the advent of AI in medical contexts also raises anxiety that AI may not be as reliable as claimed, and that laypersons are ill-equipped to make these decisions by themselves.
AI companies have a duty of care to provide their consumers with adequate notice of the risks and limitations of the AI system. But given the complex and technical nature of this information, how can such notice be made salient for consumers? The main argument of this article is that, if AI companies effectively offer a health service traditionally performed by doctors, then they should be guided by the values that govern the doctor-patient relationship regarding the information provided to consumers about the limitations of the AI system.
We propose Precision Consent, an interdisciplinary framework that draws connections between the legal and ethical duties of doctors towards their patients, and capabilities in the field of AI. We discuss how values that guide doctors, such as respect for patient autonomy, non-maleficence and personalised warnings, can be incorporated into how notice is provided to consumers regarding the accuracy of AI health services.



